new aseptic fill and finish cmo in China

Wuxi Griffin Pharmaceuticals is a new joint venture between Wuxi Fortune Pharmaceutical in China and SialoCarb in Sweden. It is to operate as an international CMO. The main focus of the western-managed joint venture is aseptic fill & finish of sterile pharmaceuticals.

SourceWuxi Griffin – a new aseptic fill contract manufacturer in China

发表评论

电子邮件地址不会被公开。 必填项已用*标注